(CE) Celanese - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1508701034

Acetyls, Engineered Polymers, Thermoplastics, Resins, Elastomers

Stock: Specialty Chemicals
Age 21y

MCap 5,140m
Avg Vol 1.72M (74.7M USD)

Beta 1.852
Volatility 51.82%

EPS (Earnings per Share)

EPS CAGR: -58.50%
EPS Trend: -80.3%

Last SUE: -3.88
Qual. Beats: 0

Revenue

Rev. CAGR: 1.65%
Rev. Trend: 9.6%

Last SUE: -1.42
Qual. Beats: 0

Dividends

Dividend Yield	0.25%
Yield on Cost 5y	0.10%
Yield CAGR 5y	-54.17%
Payout Consistency	94.7%
Payout Ratio	2.5%

Risk via 5d forecast
Volatility	51.8%
Value at Risk 5%th	78.1%
Relative Tail Risk	-8.37%

Reward TTM
Sharpe Ratio	-0.40
Alpha	-59.78
CAGR/Max DD	-0.32

Character TTM
Hurst Exponent	0.421
Beta	1.852
Beta Downside	2.298

Drawdowns 3y
Max DD	78.96%
Mean DD	33.86%
Median DD	20.27%

Description: CE Celanese January 09, 2026

Celanese Corporation (NYSE:CE) is a global chemical and specialty-materials producer that operates two primary segments. The Engineered Materials segment supplies a broad portfolio of high-performance polymers-including nylon, polypropylene, polyoxymethylene, liquid-crystal polymers, and thermoplastic elastomers-for end-markets such as automotive, medical devices, consumer electronics, and energy-storage systems. The Acetyl Chain segment manufactures acetyl-based intermediates (e.g., acetic acid, vinyl acetate monomer, ethylene-vinyl acetate resins) used in paints, coatings, adhesives, flexible packaging, and pharmaceutical applications. Products are sold under well-known brands like Zytel, Hytrel, and Santoprene, primarily through direct OEM relationships and a network of distributors.

Key operating metrics that analysts watch include • 2023 revenue of roughly $9.1 billion, with the Engineered Materials segment contributing about 55 % of total sales; • adjusted EBITDA margin hovering near 13 %-a level that reflects both pricing power in specialty polymers and exposure to volatile natural-gas feedstock costs; • capacity utilization rates of ~ 85 % across its U.S. and European plants, which can be a leading indicator of demand trends in automotive lightweighting and battery-case production. Macro-level drivers for Celanese are the global shift toward electrification (boosting demand for high-temperature polymers), cyclical construction activity (affecting polyphenylene sulfide and PVC-based products), and the price trajectory of natural gas, which accounts for roughly 30 % of its variable production costs.

For a deeper, data-driven view of Celanese’s valuation and risk profile, you may find ValueRay’s analyst toolkit useful.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (-3.09b TTM) > 0 and > 6% of Revenue (6% = 582.6m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 1.36pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 24.34% (prev 14.76%; Δ 9.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 1.39b > Net Income -3.09b (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 1.63 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (109.6m) change vs 12m ago 0.06% (target <= -2.0% for YES)

Gross Margin 21.33% (prev 23.19%; Δ -1.86pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 40.41% (prev 40.47%; Δ -0.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -2.86 (EBITDA TTM -1.28b / Interest Expense TTM 719.0m) >= 6 (WARN >= 3)

Altman Z'' 2.11

(A) 0.11 = (Total Current Assets 6.09b - Total Current Liabilities 3.73b) / Total Assets 22.17b

(B) 0.44 = Retained Earnings (Balance) 9.86b / Total Assets 22.17b

(D) 0.51 = Book Value of Equity 9.01b / Total Liabilities 17.79b

Total Rating: 2.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 31.65

1. Piotroski 3.0pt

2. FCF Yield 6.08%

3. FCF Margin 10.55%

4. Debt/Equity 3.32

5. Debt/Ebitda -9.10

6. ROIC - WACC (= -13.55)%

7. RoE -63.15%

8. Rev. Trend 9.64%

9. EPS Trend -80.35%

What is the price of CE shares?

As of January 22, 2026, the stock is trading at USD 48.12 with a total of 3,127,177 shares traded.
Over the past week, the price has changed by +2.47%, over one month by +12.64%, over three months by +15.72% and over the past year by -34.83%.

Is CE a buy, sell or hold?

Celanese has received a consensus analysts rating of 3.44. Therefor, it is recommend to hold CE.

Strong Buy: 5
Buy: 0
Hold: 12
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the CE price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	52.3	8.7%
Analysts Target Price	52.3	8.7%
ValueRay Target Price	43.8	-9.1%

CE Fundamental Data Overview January 19, 2026

P/E Forward = 8.2372
P/S = 0.5294
P/B = 1.3
P/EG = 4.4198
Revenue TTM = 9.71b USD
EBIT TTM = -2.06b USD
EBITDA TTM = -1.28b USD
Long Term Debt = 11.65b USD (from longTermDebt, last quarter)
Short Term Debt = 1.20b USD (from shortTermDebt, last quarter)
Debt = 13.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.69b USD (from netDebt column, last quarter)
Enterprise Value = 16.83b USD (5.14b + Debt 13.13b - CCE 1.44b)
Interest Coverage Ratio = -2.86 (Ebit TTM -2.06b / Interest Expense TTM 719.0m)
EV/FCF = 16.44x (Enterprise Value 16.83b / FCF TTM 1.02b)
FCF Yield = 6.08% (FCF TTM 1.02b / Enterprise Value 16.83b)
FCF Margin = 10.55% (FCF TTM 1.02b / Revenue TTM 9.71b)
Net Margin = -31.85% (Net Income TTM -3.09b / Revenue TTM 9.71b)
Gross Margin = 21.33% ((Revenue TTM 9.71b - Cost of Revenue TTM 7.64b) / Revenue TTM)
Gross Margin QoQ = 21.54% (prev 21.13%)
Tobins Q-Ratio = 0.76 (Enterprise Value 16.83b / Total Assets 22.17b)
Interest Expense / Debt = 1.35% (Interest Expense 177.0m / Debt 13.13b)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.63b (EBIT -2.06b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.63 (Total Current Assets 6.09b / Total Current Liabilities 3.73b)
Debt / Equity = 3.32 (Debt 13.13b / totalStockholderEquity, last quarter 3.95b)
Debt / EBITDA = -9.10 (negative EBITDA) (Net Debt 11.69b / EBITDA -1.28b)
Debt / FCF = 11.42 (Net Debt 11.69b / FCF TTM 1.02b)
Total Stockholder Equity = 4.90b (last 4 quarters mean from totalStockholderEquity)
RoA = -12.87% (Net Income -3.09b / Total Assets 22.17b)
RoE = -63.15% (Net Income TTM -3.09b / Total Stockholder Equity 4.90b)
RoCE = -12.44% (EBIT -2.06b / Capital Employed (Equity 4.90b + L.T.Debt 11.65b))
RoIC = -9.20% (negative operating profit) (NOPAT -1.63b / Invested Capital 17.69b)
WACC = 4.35% (E(5.14b)/V(18.27b) * Re(12.74%) + D(13.13b)/V(18.27b) * Rd(1.35%) * (1-Tc(0.21)))
Discount Rate = 12.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.05%
[DCF Debug] Terminal Value 84.22% ; FCFF base≈952.0m ; Y1≈788.6m ; Y5≈572.9m
Fair Price DCF = 53.20 (EV 17.52b - Net Debt 11.69b = Equity 5.83b / Shares 109.5m; r=5.90% [WACC]; 5y FCF grow -20.68% → 2.90% )
EPS Correlation: -80.35 | EPS CAGR: -58.50% | SUE: -3.88 | # QB: 0
Revenue Correlation: 9.64 | Revenue CAGR: 1.65% | SUE: -1.42 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.92 | Chg30d=-0.029 | Revisions Net=-3 | Analysts=10
EPS next Year (2026-12-31): EPS=5.52 | Chg30d=-0.082 | Revisions Net=-5 | Growth EPS=+30.0% | Growth Revenue=+0.1%

Additional Sources for CE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle